Search

everythinglearnresearchcommunity

for

Search:↓

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

S100A4 and NMIIA promote tumor growth in glioblastoma by enhancing blood vessel functions.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Laser technologies improve medical treatments and outcomes.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Improving how drugs are absorbed through the skin could better treat mange in wombats.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

RpoS helps Borrelia burgdorferi survive in hosts and adapt to different environments.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A new 3D culture system helps grow and study mouse skin stem cells for a long time.

PEDF reduces oxidative damage and supports stem cells.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.